✦ LIBER ✦

PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA

✍ Scribed by JC Sambrook; AR Levy; K Osenenko; C Kindundu; M Barbeau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAO6: COST-EFFECTIVENESS ANALYSIS OF USI

✍ J Soto; J Rejas 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PAR1 COSTS AND EFFECTS OF CELECOXIB IN T

✍ M Al; M Janssen; HC Monteban 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PSY28 Cost-Effectiveness Analysis of Cel

✍ J.J. Vargas-valencia; R. Orrantia-Gradín; E. Muciño-Ortega; R.M. Galindo-Suárez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Lumiracoxib is effective in the treatmen

✍ Roy Fleischmann; Eric Sheldon; José Maldonado-Cocco; Dipen Dutta; Sue Yu; Victor 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 416 KB

PAO4: THE COST-EFFECTIVENESS OF CELECOXI

✍ E Orlewska 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PAR2 THE COST-EFFECTIVENESS ANALYSIS OF

✍ O Zaliska 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB